Study tracks financial stress in families fighting childhood leukemia
NCT ID NCT04928599
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how worried parents are about money while their child is being treated for acute lymphoblastic leukemia. Researchers will survey 100 parents over time to see how financial distress changes and what factors make it better or worse. The goal is to gather information that could help design future programs to ease this burden.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could point toward ways to reduce financial stress for families of children with leukemia.
- What could go wrong
- This is an observational study, not a treatment trial. It only measures distress and does not test any intervention to reduce it.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2022
- Expected to finish
-
Mar 2028
An estimate. End dates often move.
- Lead sponsor
-
A research network
The lead sponsor is a research network or cooperative group.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Parents of children who are receiving induction chemotherapy for newly diagnosed ALL
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * All Children's Oncology Group (COG) NCI Community Oncology Research Program (National Cancer Institute \[N\]CORP) institutions are eligible for participation in this study upon first parent enrollment * Parents of an index child who meets the following characteristics are eligible for this study: * Index child must be newly diagnosed with de novo ALL * Index child must be between the ages of 1 and 14.9 years at the time of the parent's enrollment * At the parent's entry to the study, the index child must be receiving induction chemotherapy for newly diagnosed ALL at the enrolling institution. The index child may be enrolled in therapeutic clinical ALL trials or receiving ALL therapy per standard of care * Parents age 18 years and above are eligible for this study * Parent must speak English or Spanish in order to participate in the consent process and provide consent. The parent's language skills must be sufficient to understand the study requirements and complete the survey and interview questions * At the parent's entry to the study, the index child must be receiving induction chemotherapy for newly diagnosed ALL at the enrolling institution. The index child may be enrolled in therapeutic clinical ALL trials or receiving ALL therapy per standard of care * REGULATORY REQUIREMENTS: All parents must sign a written informed consent for their participation in the study * REGULATORY REQUIREMENTS: All institutional and NCI requirements for human studies must be met Exclusion Criteria: * Parents of index children with any of the following clinical characteristics will be excluded from the study: * KMT2A-R (formerly MLL-R) not receiving ALL therapy * Mixed-phenotype acute leukemia (MPAL) not receiving ALL therapy * Burkitt's leukemia
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute lymphoblastic leukemia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Alfred I duPont Hospital for Children
Wilmington, Delaware, 19803, United States
-
Alliance for Childhood Diseases/Cure 4 the Kids Foundation
Las Vegas, Nevada, 89135, United States
-
Augusta University Medical Center
Augusta, Georgia, 30912, United States
-
BI-LO Charities Children's Cancer Center
Greenville, South Carolina, 29605, United States
-
Blank Children's Hospital
Des Moines, Iowa, 50309, United States
-
Bronson Methodist Hospital
Kalamazoo, Michigan, 49007, United States
-
Broward Health Medical Center
Fort Lauderdale, Florida, 33316, United States
-
Children's Hospital New Orleans
New Orleans, Louisiana, 70118, United States
-
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
Grand Rapids, Michigan, 49503, United States
-
Dell Children's Medical Center of Central Texas
Austin, Texas, 78723, United States
-
Driscoll Children's Hospital
Corpus Christi, Texas, 78411, United States
-
El Paso Children's Hospital
El Paso, Texas, 79905, United States
-
Geisinger Medical Center
Danville, Pennsylvania, 17822, United States
-
Golisano Children's Hospital of Southwest Florida
Fort Myers, Florida, 33908, United States
-
Kaiser Permanente-Oakland
Oakland, California, 94611, United States
-
Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, 96826, United States
-
Maine Children's Cancer Program
Scarborough, Maine, 04074, United States
-
Memorial Regional Hospital/Joe DiMaggio Children's Hospital
Hollywood, Florida, 33021, United States
-
Mercy Hospital Saint Louis
St Louis, Missouri, 63141, United States
-
Methodist Children's Hospital of South Texas
San Antonio, Texas, 78229, United States
-
Montefiore Medical Center - Moses Campus
The Bronx, New York, 10467, United States
-
Morristown Medical Center
Morristown, New Jersey, 07960, United States
-
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
New York, New York, 10032, United States
-
Nemours Children's Clinic-Jacksonville
Jacksonville, Florida, 32207, United States
-
Nemours Children's Hospital
Orlando, Florida, 32827, United States
-
Ochsner Medical Center Jefferson
New Orleans, Louisiana, 70121, United States
-
Prisma Health Richland Hospital
Columbia, South Carolina, 29203, United States
-
Renown Regional Medical Center
Reno, Nevada, 89502, United States
-
Sacred Heart Hospital
Pensacola, Florida, 32504, United States
-
Saint Joseph's Hospital/Children's Hospital-Tampa
Tampa, Florida, 33607, United States
-
Saint Vincent Hospital Cancer Center Green Bay
Green Bay, Wisconsin, 54301, United States
-
Sanford Broadway Medical Center
Fargo, North Dakota, 58122, United States
-
Sanford USD Medical Center - Sioux Falls
Sioux Falls, South Dakota, 57117-5134, United States
-
Summerlin Hospital Medical Center
Las Vegas, Nevada, 89144, United States
-
Sunrise Hospital and Medical Center
Las Vegas, Nevada, 89109, United States
-
Tampa General Hospital
Tampa, Florida, 33606, United States
-
University Medical Center of Southern Nevada
Las Vegas, Nevada, 89102, United States
-
University Pediatric Hospital
San Juan, 00926, Puerto Rico
-
University of New Mexico Cancer Center
Albuquerque, New Mexico, 87106, United States
-
VCU Massey Comprehensive Cancer Center
Richmond, Virginia, 23298, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Engineered immune cells aim to wipe out stubborn leukemia
- Tweaking donor cells may shield older transplant patients from a dangerous complication
- The immune cells that could make stem cell transplants work better
- Aloe vera mouthwash tested against chemotherapy mouth sores
- Can a Chemo-Only prep beat radiation for childhood leukemia transplants?
- Can a targeted drug hit the mark in Hard-to-Treat blood cancers?